Brain scan study for people with CADASIL
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This study is testing a new brain scan tool to understand small blood vessel problems in people with CADASIL. If you have CADASIL, you'll have an MRI to help develop a way to spot these changes earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 80 years old.
- You have CADASIL confirmed by genetic testing.
- You do not have metal implants or other reasons you can't have an MRI.
- You are not pregnant, breastfeeding, or in certain legal situations described in French law.
- You are able to give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies CADASIL (a genetic blood-vessel condition in the brain) by following people over time with MRI scans, blood draws, and questionnaires. It may help researchers better understand how the condition changes and how factors like medications affect outcomes.
This study looks at how genetic and brain imaging changes relate to symptoms in people with CADASIL, a genetic condition that affects small blood vessels in the brain and can cause strokes. It aims to better understand the disease to improve future care.
This study collects blood samples and medical information from people with rare inherited blood vessel diseases of the brain, and from healthy volunteers. Researchers use this information to understand these diseases better and develop future treatments.
This study is building a group of Australians with CADASIL (a genetic condition that affects blood vessels in the brain) to learn more about the disease. As a participant, you will have a medical exam, a blood test, and a short memory test.
This study follows people with CADASIL over time to learn more about the condition. It may help researchers understand how CADASIL progresses and improve care for patients.
This study builds a group “registry” of people affected by CADASIL (a genetic brain blood-vessel condition) and people who carry the NOTCH3 mutation, even if they have no symptoms. It helps researchers learn more about the condition over time and compare experiences between patients, carriers, and healthy relatives or controls.
Hear when a new CADASIL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.